Service by

Home Journal Issues Guide for Authors Editorial Board About Aims & Scope Editorial Contact


Original Research Open Access


Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease

Geetha Raghu, Aishwarya Karunanithi, Iyanar Kannan, Lakshmi Preetha K.

Abstract
Background: Alzheimer’s disease (AD) is a progressive neurodegenerative brain disorder, and it is the main cause of dementia in the elderly. At present, no proper cure is available to stop the progression of AD. The neuronal damage in AD is due to the deposition of β-amyloid peptide and tau protein within the brain. Curcumin a curry spice has several beneficial activities such as antioxidant, antimicrobial, anti-inflammatory, and chemotherapeutic properties.

Aims and Objectives: The main objective was to perform molecular docking of curcumin and its derivatives with BACE1 to determine its binding efficacy and the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of the selected curcumin derivatives.

Materials and Methods: Three-dimensional structure of the BACE1 was retrieved from RCSB database in protein data bank format. Total 200 ligand derivatives of curcumin were generated using the software advanced chemistry development/ChemSketch. The rapid virtual screening of the compounds was performed using the docking tool iGEMDOCK version 2.0. The ligands with low binding energy were selected and were analyzed for the drug-relevant properties. The final docking of the ligands was performed using the software AutoDock 4.0, based on the drug-like properties and the binding affinity.

Results: Among the four ligands, based on the drug-likeness, the ligand (6Z)-1-(4-hydroxy-3-methoxy-2-nitrophenyl)-7-(4-hydroxy-3-methoxyohenyl) hepta-1,6-diene-3, 5-dione was the best. It had excellent binding energy with good ADMET properties.

Conclusion: In this study, using the molecular docking method, a new compound has been identified to inhibit BACE1. This compound can be an effective drug candidate for controlling AD.

Key words: Molecular Docking; Curcumin; Alzheimer’s Disease; BACE1


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Geetha Raghu
Articles by Aishwarya Karunanithi
Articles by Iyanar Kannan
Articles by Lakshmi Preetha K
on Google
on Google Scholar
Article Statistics
 Viewed: 217
Downloaded: 101
Cited: 0


How to Cite this Article
Pubmed Style

Raghu G, Karunanithi A, Kannan I, K LP. Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. Natl J Physiol Pharm Pharmacol. 2018; 8(2): 244-250. doi:10.5455/njppp.2017.7.1038623102017


Web Style

Raghu G, Karunanithi A, Kannan I, K LP. Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. http://www.njppp.com/?mno=279934 [Access: February 23, 2018]. doi:10.5455/njppp.2017.7.1038623102017


AMA (American Medical Association) Style

Raghu G, Karunanithi A, Kannan I, K LP. Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. Natl J Physiol Pharm Pharmacol. 2018; 8(2): 244-250. doi:10.5455/njppp.2017.7.1038623102017



Vancouver/ICMJE Style

Raghu G, Karunanithi A, Kannan I, K LP. Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. Natl J Physiol Pharm Pharmacol. (2018), [cited February 23, 2018]; 8(2): 244-250. doi:10.5455/njppp.2017.7.1038623102017



Harvard Style

Raghu, G., Karunanithi, A., Kannan, I. & K, L. P. (2018) Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. Natl J Physiol Pharm Pharmacol, 8 (2), 244-250. doi:10.5455/njppp.2017.7.1038623102017



Turabian Style

Raghu, Geetha, Aishwarya Karunanithi, Iyanar Kannan, and Lakshmi Preetha K. 2018. Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. National Journal of Physiology, Pharmacy and Pharmacology, 8 (2), 244-250. doi:10.5455/njppp.2017.7.1038623102017



Chicago Style

Raghu, Geetha, Aishwarya Karunanithi, Iyanar Kannan, and Lakshmi Preetha K. "Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease." National Journal of Physiology, Pharmacy and Pharmacology 8 (2018), 244-250. doi:10.5455/njppp.2017.7.1038623102017



MLA (The Modern Language Association) Style

Raghu, Geetha, Aishwarya Karunanithi, Iyanar Kannan, and Lakshmi Preetha K. "Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease." National Journal of Physiology, Pharmacy and Pharmacology 8.2 (2018), 244-250. Print. doi:10.5455/njppp.2017.7.1038623102017



APA (American Psychological Association) Style

Raghu, G., Karunanithi, A., Kannan, I. & K, L. P. (2018) Molecular docking study on curcumin and its derivatives as inhibitors of BACE1 in the treatment of Alzheimer’s disease. National Journal of Physiology, Pharmacy and Pharmacology, 8 (2), 244-250. doi:10.5455/njppp.2017.7.1038623102017



AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

 

National Journal of Physiology, Pharmacy and Pharmacology is Indexed in -

EMBASE

Index Copernicus  (ICV 2016: 109)

Index Medicus for SEAR

CAB abstract/Global Health

CINAHL

Hinari

Google Scholar

ScopeMed

Ulrich’s International Periodical Directory

Indian Science Abstracts

Open J- Gate

Geneva Foundation for Medical Education and Research

NewJour

PSOAR

InformIndia

EBSCO Publishing Electronic Database

Genamics JournalSeek

ProQuest

Index Scholar

SafetyLit

Chemical Abstracts Service (CAS)

Gale's Health Reference Center

Gale Info Trac

Gale Academic Onefile

Ind Medica

Scirus

Scientific Publication Index

Scientific Resources Database

Recent Science Index

Scholarly Journals Index

Directory of Academic Resources

Elite Scientific Journals Archives

Current Index to Scholarly Journals

Digital Journals Database

Academic Papers Database

Contemporary Research Index

Ayush Web Portal

CiteFactor

 

 

 

 

 

 

Journal Membership

World Association of Medical Editors (WAME), Dallas, Texas, USA

 

Journal Listed in

ICMJE- International Committee of Medical Journal Editors

HIFA 2015 – Healthcare Information for All by 2015, Charlbury, Oxfordshire, UK 

 

 


The articles in this Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.